BUSINESS WIRE)-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on ... Presenter: Stephen A. Harrison, M.D., Medical Director of Pinnacle Clinical Research in San Antonio, TX, visiting professor of ...
News
- Axcella Announces Upcoming Later-Breaker Presentation at The Digital International Liver ...
- Best colleges in big cities
It's close to downtown San Antonio, a booming city of biotech and ... of the University of Minnesota, students tend to concentrate in biological sciences, ...
- Target, Momenta Pharmaceuticals rise; BioMarin, TJX fall
Johnson & Johnson is buying the biotechnology company for $6.5 billion. Hudson Ltd., up $2.33 to $7.46. Dufry Group AG, the travel retailer's majority ...
- Unite Private Networks Announces Major Network Expansion Into San Antonio, TX
“Strong fiber infrastructure is critical to San Antonio's ever-growing cyber, tech, bioscience, and manufacturing sectors. We're excited to welcome Unite ...
- Postdoctoral fellow awarded NIH grant for nanoparticle research
AUGUST 19, 2020 — Maria Gonzalez Porras, a postdoctoral fellow in the Department of Biomedical Engineering and Chemical Engineering at UTSA ...